Presentation TCT 2013 Data Presented to the FDA to Support a Degenerative MR Indication in Patients Too High Risk for Surgery Presenter: Saibal Kar October 28, 2013 REGISTER for free or LOG IN to view this content Mitral Valve Presentation TCT 2013 Up Next Presentation TCT 2013 REVIVE-IT Presenter: Keith Aaronson October 28, 2013 More slides + Presentation TCT 2013 Impact of Incomplete Revascularization, and the Central Role of CTOs Presenter: Gerald Werner October 28, 2013 Presentation TCT 2013 Proactive Measures Have Reduced Major Vascular Complications After TAVR to < 5%: The Vancouver Experience Presenter: John Webb October 28, 2013 We Recommend
Presentation TCT 2013 Impact of Incomplete Revascularization, and the Central Role of CTOs Presenter: Gerald Werner October 28, 2013
Presentation TCT 2013 Proactive Measures Have Reduced Major Vascular Complications After TAVR to < 5%: The Vancouver Experience Presenter: John Webb October 28, 2013